Fundies.
English

Segment disclosures

Company overview

Convey Health Solutions Holdings, Inc.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

22 dimension combinations 202 retained observations 11 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Consulting · Advisory Services

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=cnvy:ConsultingMember;us-gaap:StatementBusinessSegmentsAxis=cnvy:AdvisoryServicesMember
PeriodValueUnitFiledEvidence
2022-01-01 – 2022-03-3113457000 USD20220510Open filing evidence
2021-01-01 – 2021-12-3152849000 USD20220323Open filing evidence
2021-07-01 – 2021-09-3013090000 USD20211110Open filing evidence
2021-01-01 – 2021-09-3040021000 USD20211110Open filing evidence
2021-01-01 – 2021-03-3113049000 USD20220510Open filing evidence
2020-01-01 – 2020-12-3141578000 USD20220323Open filing evidence
2020-07-01 – 2020-09-309472000 USD20211110Open filing evidence
2020-01-01 – 2020-09-3028983000 USD20211110Open filing evidence
2019-06-13 – 2019-12-3113885000 USD20220323Open filing evidence
2019-01-01 – 2019-09-0330806000 USD20220323Open filing evidence

Consulting · Technology Enabled Solutions

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=cnvy:ConsultingMember;us-gaap:StatementBusinessSegmentsAxis=cnvy:TechnologyEnabledSolutionsMember
PeriodValueUnitFiledEvidence
2022-04-01 – 2022-06-30-473000 USD20220812Open filing evidence
2022-01-01 – 2022-06-301853000 USD20220812Open filing evidence
2021-01-01 – 2021-12-316023000 USD20220323Open filing evidence
2021-07-01 – 2021-09-301671000 USD20211110Open filing evidence
2021-01-01 – 2021-09-304153000 USD20211110Open filing evidence
2021-04-01 – 2021-06-301445000 USD20220812Open filing evidence
2021-01-01 – 2021-06-302483000 USD20220812Open filing evidence
2020-01-01 – 2020-12-314754000 USD20220323Open filing evidence
2020-07-01 – 2020-09-301969000 USD20211110Open filing evidence
2020-01-01 – 2020-09-303604000 USD20211110Open filing evidence
2019-06-13 – 2019-12-311701000 USD20220323Open filing evidence
2019-01-01 – 2019-09-031553000 USD20220323Open filing evidence

Data Analytics · Advisory Services

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=cnvy:DataAnalyticsMember;us-gaap:StatementBusinessSegmentsAxis=cnvy:AdvisoryServicesMember
PeriodValueUnitFiledEvidence
2021-01-01 – 2021-12-310 USD20220323Open filing evidence
2021-07-01 – 2021-09-300 USD20211110Open filing evidence
2021-01-01 – 2021-09-300 USD20211110Open filing evidence
2020-01-01 – 2020-12-310 USD20220323Open filing evidence
2020-07-01 – 2020-09-300 USD20211110Open filing evidence
2020-01-01 – 2020-09-300 USD20211110Open filing evidence
2019-06-13 – 2019-12-310 USD20220323Open filing evidence
2019-01-01 – 2019-09-030 USD20220323Open filing evidence

Data Analytics · Technology Enabled Solutions

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=cnvy:DataAnalyticsMember;us-gaap:StatementBusinessSegmentsAxis=cnvy:TechnologyEnabledSolutionsMember
PeriodValueUnitFiledEvidence
2022-04-01 – 2022-06-303475000 USD20220812Open filing evidence
2022-01-01 – 2022-06-306033000 USD20220812Open filing evidence
2021-01-01 – 2021-12-3111659000 USD20220323Open filing evidence
2021-07-01 – 2021-09-302902000 USD20211110Open filing evidence
2021-01-01 – 2021-09-309268000 USD20211110Open filing evidence
2021-04-01 – 2021-06-303597000 USD20220812Open filing evidence
2021-01-01 – 2021-06-306365000 USD20220812Open filing evidence
2020-01-01 – 2020-12-3110680000 USD20220323Open filing evidence
2020-07-01 – 2020-09-302372000 USD20211110Open filing evidence
2020-01-01 – 2020-09-307293000 USD20211110Open filing evidence
2020-04-01 – 2020-06-302942000 USD20210812Open filing evidence
2020-01-01 – 2020-06-304920000 USD20210812Open filing evidence
2019-06-13 – 2019-12-314612000 USD20220323Open filing evidence
2019-01-01 – 2019-09-038475000 USD20220323Open filing evidence

Health Care · Advisory Services

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=us-gaap:HealthCareMember;us-gaap:StatementBusinessSegmentsAxis=cnvy:AdvisoryServicesMember
PeriodValueUnitFiledEvidence
2022-04-01 – 2022-06-300 USD20220812Open filing evidence
2022-01-01 – 2022-06-300 USD20220812Open filing evidence
2022-01-01 – 2022-03-310 USD20220510Open filing evidence
2021-01-01 – 2021-12-310 USD20220323Open filing evidence
2021-04-01 – 2021-06-300 USD20220812Open filing evidence
2021-01-01 – 2021-06-300 USD20220812Open filing evidence
2021-01-01 – 2021-03-310 USD20220510Open filing evidence
2020-01-01 – 2020-12-310 USD20220323Open filing evidence
2019-06-13 – 2019-12-310 USD20220323Open filing evidence
2019-01-01 – 2019-09-030 USD20220323Open filing evidence

Health Care · Technology Enabled Solutions

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=us-gaap:HealthCareMember;us-gaap:StatementBusinessSegmentsAxis=cnvy:TechnologyEnabledSolutionsMember
PeriodValueUnitFiledEvidence
2022-04-01 – 2022-06-3024035000 USD20220812Open filing evidence
2022-01-01 – 2022-06-3049897000 USD20220812Open filing evidence
2021-01-01 – 2021-12-3193150000 USD20220323Open filing evidence
2021-04-01 – 2021-06-3021166000 USD20220812Open filing evidence
2021-01-01 – 2021-06-3045107000 USD20220812Open filing evidence
2020-01-01 – 2020-12-3176814000 USD20220323Open filing evidence
2020-04-01 – 2020-06-3017846000 USD20210812Open filing evidence
2020-01-01 – 2020-06-3037460000 USD20210812Open filing evidence
2019-06-13 – 2019-12-3125571000 USD20220323Open filing evidence
2019-01-01 – 2019-09-0345245000 USD20220323Open filing evidence

Product · Advisory Services

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=cnvy:AdvisoryServicesMember
PeriodValueUnitFiledEvidence
2022-04-01 – 2022-06-300 USD20220812Open filing evidence
2022-01-01 – 2022-06-300 USD20220812Open filing evidence
2021-04-01 – 2021-06-300 USD20220812Open filing evidence
2021-01-01 – 2021-06-300 USD20220812Open filing evidence

Product · Technology Enabled Solutions

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=cnvy:TechnologyEnabledSolutionsMember
PeriodValueUnitFiledEvidence
2022-04-01 – 2022-06-3045954000 USD20220812Open filing evidence
2022-01-01 – 2022-06-3096182000 USD20220812Open filing evidence
2021-04-01 – 2021-06-3032964000 USD20220812Open filing evidence
2021-01-01 – 2021-06-3072069000 USD20220812Open filing evidence
2020-04-01 – 2020-06-3028439000 USD20210812Open filing evidence
2020-01-01 – 2020-06-3058698000 USD20210812Open filing evidence

Technology Service · Advisory Services

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=us-gaap:TechnologyServiceMember;us-gaap:StatementBusinessSegmentsAxis=cnvy:AdvisoryServicesMember
PeriodValueUnitFiledEvidence
2022-04-01 – 2022-06-3020000 USD20220812Open filing evidence
2022-01-01 – 2022-06-30105000 USD20220812Open filing evidence
2022-01-01 – 2022-03-3185000 USD20220510Open filing evidence
2021-04-01 – 2021-06-300 USD20220812Open filing evidence
2021-01-01 – 2021-06-300 USD20220812Open filing evidence
2021-01-01 – 2021-03-310 USD20220510Open filing evidence

Technology Service · Technology Enabled Solutions

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=us-gaap:TechnologyServiceMember;us-gaap:StatementBusinessSegmentsAxis=cnvy:TechnologyEnabledSolutionsMember
PeriodValueUnitFiledEvidence
2022-04-01 – 2022-06-302628000 USD20220812Open filing evidence
2022-01-01 – 2022-06-304820000 USD20220812Open filing evidence
2021-04-01 – 2021-06-302194000 USD20220812Open filing evidence
2021-01-01 – 2021-06-304925000 USD20220812Open filing evidence

Advisory Services

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cnvy:AdvisoryServicesMember
PeriodValueUnitFiledEvidence
2022-04-01 – 2022-06-3014163000 USD20220812Open filing evidence
2022-01-01 – 2022-06-3027705000 USD20220812Open filing evidence
2022-01-01 – 2022-03-3113542000 USD20220510Open filing evidence
2021-01-01 – 2021-12-3152977000 USD20220323Open filing evidence
2021-07-01 – 2021-09-3013163000 USD20211110Open filing evidence
2021-01-01 – 2021-09-3040094000 USD20211110Open filing evidence
2021-04-01 – 2021-06-3013882000 USD20220812Open filing evidence
2021-01-01 – 2021-06-3026931000 USD20220812Open filing evidence
2021-01-01 – 2021-03-3113049000 USD20220510Open filing evidence
2020-01-01 – 2020-12-3141578000 USD20220323Open filing evidence
2020-07-01 – 2020-09-309472000 USD20211110Open filing evidence
2020-01-01 – 2020-09-3028983000 USD20211110Open filing evidence
2020-04-01 – 2020-06-309459000 USD20210812Open filing evidence
2020-01-01 – 2020-06-3019511000 USD20210812Open filing evidence
2019-06-13 – 2019-12-3113885000 USD20220323Open filing evidence
2019-01-01 – 2019-09-0330806000 USD20220323Open filing evidence

Advisory Services · Consulting

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cnvy:AdvisoryServicesMember;srt:ProductOrServiceAxis=cnvy:ConsultingMember
PeriodValueUnitFiledEvidence
2022-04-01 – 2022-06-3014143000 USD20220812Open filing evidence
2022-01-01 – 2022-06-3027600000 USD20220812Open filing evidence
2021-04-01 – 2021-06-3013882000 USD20220812Open filing evidence
2021-01-01 – 2021-06-3026931000 USD20220812Open filing evidence
2020-04-01 – 2020-06-309459000 USD20210812Open filing evidence
2020-01-01 – 2020-06-3019511000 USD20210812Open filing evidence

Advisory Services · Data Analytics

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cnvy:AdvisoryServicesMember;srt:ProductOrServiceAxis=cnvy:DataAnalyticsMember
PeriodValueUnitFiledEvidence
2022-04-01 – 2022-06-300 USD20220812Open filing evidence
2022-01-01 – 2022-06-300 USD20220812Open filing evidence
2022-01-01 – 2022-03-310 USD20220510Open filing evidence
2021-04-01 – 2021-06-300 USD20220812Open filing evidence
2021-01-01 – 2021-06-300 USD20220812Open filing evidence
2021-01-01 – 2021-03-310 USD20220510Open filing evidence
2020-04-01 – 2020-06-300 USD20210812Open filing evidence
2020-01-01 – 2020-06-300 USD20210812Open filing evidence

Advisory Services · Health Care

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cnvy:AdvisoryServicesMember;srt:ProductOrServiceAxis=us-gaap:HealthCareMember
PeriodValueUnitFiledEvidence
2021-07-01 – 2021-09-300 USD20211110Open filing evidence
2021-01-01 – 2021-09-300 USD20211110Open filing evidence
2021-04-01 – 2021-06-300 USD20210812Open filing evidence
2021-01-01 – 2021-06-300 USD20210812Open filing evidence
2020-07-01 – 2020-09-300 USD20211110Open filing evidence
2020-01-01 – 2020-09-300 USD20211110Open filing evidence
2020-04-01 – 2020-06-300 USD20210812Open filing evidence
2020-01-01 – 2020-06-300 USD20210812Open filing evidence

Advisory Services · Product

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cnvy:AdvisoryServicesMember;srt:ProductOrServiceAxis=us-gaap:ProductMember
PeriodValueUnitFiledEvidence
2022-01-01 – 2022-03-310 USD20220510Open filing evidence
2021-01-01 – 2021-12-310 USD20220323Open filing evidence
2021-07-01 – 2021-09-300 USD20211110Open filing evidence
2021-01-01 – 2021-09-300 USD20211110Open filing evidence
2021-04-01 – 2021-06-300 USD20210812Open filing evidence
2021-01-01 – 2021-06-300 USD20210812Open filing evidence
2021-01-01 – 2021-03-310 USD20220510Open filing evidence
2020-01-01 – 2020-12-310 USD20220323Open filing evidence
2020-07-01 – 2020-09-300 USD20211110Open filing evidence
2020-01-01 – 2020-09-300 USD20211110Open filing evidence
2020-04-01 – 2020-06-300 USD20210812Open filing evidence
2020-01-01 – 2020-06-300 USD20210812Open filing evidence
2019-06-13 – 2019-12-310 USD20220323Open filing evidence
2019-01-01 – 2019-09-030 USD20220323Open filing evidence

Advisory Services · Technology Service

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cnvy:AdvisoryServicesMember;srt:ProductOrServiceAxis=us-gaap:TechnologyServiceMember
PeriodValueUnitFiledEvidence
2021-01-01 – 2021-12-31128000 USD20220323Open filing evidence
2021-07-01 – 2021-09-3073000 USD20211110Open filing evidence
2021-01-01 – 2021-09-3073000 USD20211110Open filing evidence
2021-04-01 – 2021-06-300 USD20210812Open filing evidence
2021-01-01 – 2021-06-300 USD20210812Open filing evidence
2020-01-01 – 2020-12-310 USD20220323Open filing evidence
2020-07-01 – 2020-09-300 USD20211110Open filing evidence
2020-01-01 – 2020-09-300 USD20211110Open filing evidence
2020-04-01 – 2020-06-300 USD20210812Open filing evidence
2020-01-01 – 2020-06-300 USD20210812Open filing evidence
2019-06-13 – 2019-12-310 USD20220323Open filing evidence
2019-01-01 – 2019-09-030 USD20220323Open filing evidence

Technology Enabled Solutions

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cnvy:TechnologyEnabledSolutionsMember
PeriodValueUnitFiledEvidence
2022-04-01 – 2022-06-3075619000 USD20220812Open filing evidence
2022-01-01 – 2022-06-30158785000 USD20220812Open filing evidence
2022-01-01 – 2022-03-3183166000 USD20220510Open filing evidence
2021-01-01 – 2021-12-31284619000 USD20220323Open filing evidence
2021-07-01 – 2021-09-3069248000 USD20211110Open filing evidence
2021-01-01 – 2021-09-30200196000 USD20211110Open filing evidence
2021-04-01 – 2021-06-3061366000 USD20220812Open filing evidence
2021-01-01 – 2021-06-30130949000 USD20220812Open filing evidence
2021-01-01 – 2021-03-3169582000 USD20220510Open filing evidence
2020-01-01 – 2020-12-31241336000 USD20220323Open filing evidence
2020-07-01 – 2020-09-3060056000 USD20211110Open filing evidence
2020-01-01 – 2020-09-30166850000 USD20211110Open filing evidence
2020-04-01 – 2020-06-3052103000 USD20210812Open filing evidence
2020-01-01 – 2020-06-30106794000 USD20210812Open filing evidence
2019-06-13 – 2019-12-3166530000 USD20220323Open filing evidence
2019-01-01 – 2019-09-03109932000 USD20220323Open filing evidence

Technology Enabled Solutions · Consulting

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cnvy:TechnologyEnabledSolutionsMember;srt:ProductOrServiceAxis=cnvy:ConsultingMember
PeriodValueUnitFiledEvidence
2022-01-01 – 2022-03-312327000 USD20220510Open filing evidence
2021-04-01 – 2021-06-301445000 USD20210812Open filing evidence
2021-01-01 – 2021-06-302483000 USD20210812Open filing evidence
2021-01-01 – 2021-03-311038000 USD20220510Open filing evidence
2020-04-01 – 2020-06-30842000 USD20210812Open filing evidence
2020-01-01 – 2020-06-301636000 USD20210812Open filing evidence

Technology Enabled Solutions · Data Analytics

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cnvy:TechnologyEnabledSolutionsMember;srt:ProductOrServiceAxis=cnvy:DataAnalyticsMember
PeriodValueUnitFiledEvidence
2022-01-01 – 2022-03-312558000 USD20220510Open filing evidence
2021-01-01 – 2021-03-312768000 USD20220510Open filing evidence

Technology Enabled Solutions · Health Care

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cnvy:TechnologyEnabledSolutionsMember;srt:ProductOrServiceAxis=us-gaap:HealthCareMember
PeriodValueUnitFiledEvidence
2022-01-01 – 2022-03-3125862000 USD20220510Open filing evidence
2021-07-01 – 2021-09-3020750000 USD20211110Open filing evidence
2021-01-01 – 2021-09-3065856000 USD20211110Open filing evidence
2021-01-01 – 2021-03-3123942000 USD20220510Open filing evidence
2020-07-01 – 2020-09-3018334000 USD20211110Open filing evidence
2020-01-01 – 2020-09-3055795000 USD20211110Open filing evidence

Technology Enabled Solutions · Product

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cnvy:TechnologyEnabledSolutionsMember;srt:ProductOrServiceAxis=us-gaap:ProductMember
PeriodValueUnitFiledEvidence
2022-01-01 – 2022-03-3150228000 USD20220510Open filing evidence
2021-01-01 – 2021-12-31160021000 USD20220323Open filing evidence
2021-07-01 – 2021-09-3038220000 USD20211110Open filing evidence
2021-01-01 – 2021-09-30110288000 USD20211110Open filing evidence
2021-01-01 – 2021-03-3139104000 USD20220510Open filing evidence
2020-01-01 – 2020-12-31135723000 USD20220323Open filing evidence
2020-07-01 – 2020-09-3032321000 USD20211110Open filing evidence
2020-01-01 – 2020-09-3091019000 USD20211110Open filing evidence
2019-06-13 – 2019-12-3129262000 USD20220323Open filing evidence
2019-01-01 – 2019-09-0348293000 USD20220323Open filing evidence

Technology Enabled Solutions · Technology Service

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cnvy:TechnologyEnabledSolutionsMember;srt:ProductOrServiceAxis=us-gaap:TechnologyServiceMember
PeriodValueUnitFiledEvidence
2022-01-01 – 2022-03-312191000 USD20220510Open filing evidence
2021-01-01 – 2021-12-3113766000 USD20220323Open filing evidence
2021-07-01 – 2021-09-305705000 USD20211110Open filing evidence
2021-01-01 – 2021-09-3010631000 USD20211110Open filing evidence
2021-04-01 – 2021-06-302194000 USD20210812Open filing evidence
2021-01-01 – 2021-06-304925000 USD20210812Open filing evidence
2021-01-01 – 2021-03-312730000 USD20220510Open filing evidence
2020-01-01 – 2020-12-3113365000 USD20220323Open filing evidence
2020-07-01 – 2020-09-305060000 USD20211110Open filing evidence
2020-01-01 – 2020-09-309139000 USD20211110Open filing evidence
2020-04-01 – 2020-06-302034000 USD20210812Open filing evidence
2020-01-01 – 2020-06-304080000 USD20210812Open filing evidence
2019-06-13 – 2019-12-315384000 USD20220323Open filing evidence
2019-01-01 – 2019-09-036366000 USD20220323Open filing evidence